• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Feb 25;28(4).
doi: 10.3201/eid2804.212354. Online ahead of print.
Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Isabel Griffin, Kate R Woodworth, Romeo R Galang, Veronica K Burkel, Varsha Neelam, Samantha Siebman, Jerusha Barton, Susan E Manning, Kathryn Aveni, Nicole D Longcore, Elizabeth M Harvey, Van Ngo, Deborah Mbotha, Sarah Chicchelly, Mamie Lush, Valorie Eckert, Paula Dzimira, Ayomide Sokale, Miguel Valencia-Prado, Eduardo Azziz-Baumgartner, Adam MacNeil, Suzanne M Gilboa, Van T Tong
Free article

Abstract

The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.

Keywords: 2019 Novel Coronavirus Disease; COVID-19; RT-PCR; SARS-CoV-2; United States; coronavirus disease; pregnancy; real-time reverse transcription PCR; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom